NCT02772419View on ClinicalTrials.gov

Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 27, 2017

Study Completion Date

March 27, 2017

Conditions
Eosinophilic Chronic Rhinosinusitis
Interventions
DRUG

benralizumab

SC administration

DRUG

benralizumab

SC administration

DRUG

Placebo

SC administration

Trial Locations (1)

Unknown

Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02772419 - Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter